In accordance with our results, analysis of expression data from the TCGA GBM cohort using the GlioVis data visualization tool [16] revealed that NR3C2 expression is significantly reduced in glioma tumors compared to normal tissue (Figure 1B). The gene discussed is NR3C2; the disease is central nervous system cancer.